Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:351732.
doi: 10.1155/2015/351732. Epub 2015 Aug 2.

Selected Aspects in the Pathogenesis of Autoimmune Diseases

Affiliations
Review

Selected Aspects in the Pathogenesis of Autoimmune Diseases

György Nagy et al. Mediators Inflamm. 2015.

Abstract

Autoimmune processes can be found in physiological circumstances. However, they are quenched with properly functioning regulatory mechanisms and do not evolve into full-blown autoimmune diseases. Once developed, autoimmune diseases are characterized by signature clinical features, accompanied by sustained cellular and/or humoral immunological abnormalities. Genetic, environmental, and hormonal defects, as well as a quantitative and qualitative impairment of immunoregulatory functions, have been shown in parallel to the relative dominance of proinflammatory Th17 cells in many of these diseases. In this review we focus on the derailed balance between regulatory and Th17 cells in the pathogenesis of autoimmune diseases. Additionally, we depict a cytokine imbalance, which gives rise to a biased T-cell homeostasis. The assessment of Th17/Treg-cell ratio and the simultaneous quantitation of cytokines, may give a useful diagnostic tool in autoimmune diseases. We also depict the multifaceted role of dendritic cells, serving as antigen presenting cells, contributing to the development of the pathognomonic cytokine signature and promote cellular and humoral autoimmune responses. Finally we describe the function and role of extracellular vesicles in particular autoimmune diseases. Targeting these key players of disease progression in patients with autoimmune diseases by immunomodulating therapy may be beneficial in future therapeutic strategies.

PubMed Disclaimer

References

    1. Lleo A., Invernizzi P., Gao B., Podda M., Gershwin M. E. Definition of human autoimmunity—autoantibodies versus autoimmune disease. Autoimmunity Reviews. 2010;9(5):A259–A266. doi: 10.1016/j.autrev.2009.12.002. - DOI - PubMed
    1. Abbas A. K., Lohr J., Knoechel B., Nagabhushanam V. T cell tolerance and autoimmunity. Autoimmunity Reviews. 2004;3(7-8):471–475. doi: 10.1016/j.autrev.2004.07.004. - DOI - PubMed
    1. Davies A. J. S. Immunological tolerance and the autoimmune response. Autoimmunity Reviews. 2008;7(7):538–543. doi: 10.1016/j.autrev.2008.04.007. - DOI - PubMed
    1. Ermann J., Fathman C. G. Autoimmune diseases: genes, bugs and failed regulation. Nature Immunology. 2001;2(9):759–761. doi: 10.1038/ni0901-759. - DOI - PubMed
    1. Cooper G. S., Miller F. W., Pandey J. P. The role of genetic factors in autoimmune disease: implications for environmental research. Environmental Health Perspectives. 1999;107(5):693–700. doi: 10.1289/ehp.99107s5693. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources